FDA Import Refusal SCS-5264607-6/11/1 — PHARMAX LIFESCIENCES
The FDA refused shipment SCS-5264607-6/11/1 from PHARMAX LIFESCIENCES (India) on Sep 27, 2024. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 4 other import refusals on record.
Refusal details
- Date
- Sep 27, 2024
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75